Effects of serum and insulin-like growth factors on human neuroblastoma cell growth by Meghani, Mihir A. et al.
Regulatory Peptides, 48 (1993) 217-224 
© 1993 Elsevier Science Publishers B.V. All rights reserved 0167-0115/93/$06.00 
217 
REGPEP 01555 
Effects of serum and insulin-like growth factors on human 
neuroblastoma cell growth 
Mihir A. Meghani,  D o n n a  M. Martin,  J. Robinson Singleton and Eva L. Fe ldman  
Department of Neurology and the Neuroscience Program, The University of Michigan, Ann Arbor, MI (USA) 
(Received 18 March 1993; revised version received and accepted 6 March 1993) 
Key words: Insulin-like growth factor; mRNA; Proliferation; Serum; Antibody; SH-SY5Y 
Summary 
Insulin-like growth factors (IGF-I and IGF-II) are mitogenic polypeptides expressed in both developing and 
adult tissues. To examine the effects of IGFs on neuronal growth, we used SH-SY5Y neuroblastoma cells as 
an in vitro model of nervous system development. In the current study, we found that either IGF-I (0.1 to 
10 nM), insulin (0.1 to 5 #g/ml) or calf serum (0.1 to 3Yo) increased SH-SY5Y proliferation over a 3 day pe- 
riod in a dose dependent manner. In each case, treatment with anti-IGF-I receptor antibodies blocked cell 
proliferation. IGF-II mRNA levels correlated with SH-SY5Y cell density; subconfluent cells expressed high 
levels of IGF-II mRNA while low levels of IGF-II mRNA were present in confluent cells. Similarly, serum 
deprivation increased IGF-I receptor mRNA by 4-fold. Collectively, these results support the concept that an 
IGF/IGF-I  receptor system at least partially mediates SH-SY5Y cell proliferation and suggests the importance 
of IGFs in regulating neuronal growth. 
Introduction 
The insulin-like growth factors (IGF-I and IGF- 
II) belong to a family of polypeptides which pro- 
motes neuronal growth and survival [ 1 ]. During de- 
velopment, high levels of IGF transcripts are present 
Correspondence to: E.L. Feldman, 1120C Neuroscience Labora- 
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in the mammalian nervous system [2]. IGF-II can 
stimulate DNA synthesis and proliferation in fetal 
neuroblasts [3-5] and both IGF-I and IGF-II pro- 
mote survival as well as vigorous neuritic outgrowth 
of cultured chick sensory and sympathetic neurons 
[4]. Like other polypeptides, effects of the IGFs are 
mediated through binding to specific receptors. The 
IGF-I receptor, with a strong homology to the insulin 
receptor, is a tetrameric protein with intrinsic 
tyrosine-kinase activity [6]. The IGF-II/mannose 
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6-phosphate (IGF-II/M6P) receptor has a unique 
monomeric structure with distinct binding sites for 
IGF-II and M6P and is responsible for lysosomal 
enzyme trafficking [7]. The growth promoting effects 
of the IGFs are mediated primarily via the IGF-I 
receptor [8-10]. The role of the IGF-II/M6P recep- 
tor in IGF signal transduction is less clear [8]. 
Cloned SH-SY5Y neuroblastoma cells, believed 
to have arisen from neural crest cells [11 ], provide 
a good model system for examining the growth pro- 
moting effects of IGFs. These cells express IGF-II 
but not IGF-I mRNA [12] and possess functional 
IGF receptors [13-15]. We have reported that SH- 
SY5Y cells undergo density dependent autocrine 
growth, and, within 24 h of serum deprivation, ex- 
press increased levels of IGF-II mRNA followed by 
secretion of immunoreactive IGF-II protein [16]. 
Exogenous addition of IGF II enhances SH-SY5Y 
growth, while treatment with anti-IGF-II antibody or 
anti-IGF-I receptor antibody (~-IR 3) partially blocks 
autocrine growth [ 16,17]. 
In the current study, we have extended our inital 
observations on the regulation of SH-SY5Y growth. 
We report that insulin and IGF-I increase SH-SY5Y 
proliferation via the IGF-I receptor, and that this 
receptor partially mediates calf serum-stimulated 
growth. Furthermore, expression of the IGF-II and 
IGF-I receptor genes exhibit serum and density de- 
pendence. Our results provide further evidence that 
neuroblastoma cell growth is mediated via an IGF/ 
IGF-I receptor system. This work extends our 
knowledge of IGF growth-promoting mechanisms, 
and indicates that insulin and IGFs are important in 
autocrine and serum-stimulated neuroblastoma cell 
growth. 
Materials and Methods 
Cell culture flasks were purchased from Corning 
Glass Works (Corning, NY), and Costar (Cam- 
bridge, MA). Calf serum (CS) and Dulbecco's modi- 
fied Eagle's medium (DMEM) were obtained from 
Gibco BRL (Gaithersburg, MD). Restriction en- 
zymes were from Boehringer-Mannheim (Indianapo- 
lis, IN) and Gibco BRL. Polyclonal IgG against 
human IGF-I receptor (ct-IR3) was obtained from 
Oncogene Science (Uniondale, NY). IGF-I was pur- 
chased from Bachem (Torrance, CA). All other 
chemicals were purchased from Sigma Chemical 
Company (St. Louis, MO). 
Cell culture 
SH-SY5Y human neuroblastoma cells were gen- 
erously provided by Dr. Stephen Fisher, University 
of Michigan Medical Center. Cells were subcultured 
in 75 cm 2 culture flasks in DMEM and 10~o CS, and 
maintained at 37°C in a humidified atmosphere 
with 10~o CO2. The medium was changed every 2-3 
days. 
Cell proliferation assay 
Cells were washed twice with DMEM and plated 
at a density of 9.10 4 cells/cm 2 in 96-well plates in 
100 #1 DMEM with or without CS, 1 #g/ml ~-IR 3, 
IGF-I (0.1, 1, 3, and 10 nM), or insulin (0.1, 1, 3, and 
5/~g/ml). Cell proliferation was measured by using 
the MTT colorimetric assay as previously described 
[16,18]. At each time point, 25 #1 of MTT (3 (4,5- 
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro- 
mide) was added (1 mg/ml) for a 2 h incubation at 
37°C in a humidified atmosphere with 10~o CO2. 
Next, 100 /A lysis buffer (0.1 ml of 50~o dimethyl 
formamide, 20~o (w/v) SDS, pH 4.7) was added 
and the cells were incubated in the dark overnight. 
The absorbance (A) of each well was measured at 
a wavelength of 570-595 nm by a Bio-Rad Model 
2550 EIA reader (Bio-Rad Laboratories, Melville, 
NY). 
Northern analysis and cDNA probes 
SH-SY5Y cells were plated ((2-16). 10 4 cells/cm 2 
in T150 flasks) in DMEM and 10~o CS and grown 
for 2 days. The medium was then removed, the cells 
were washed twice in DMEM, and DMEM with or 
without 10~o CS was added. RNA was extracted 
either immediately (no media change) or 1, 2, or 3 
days after this medium change. Northern analysis 
was performed as previously reported [12]. RNA 
(20 #g) was electrophoresed in formaldehyde- 
agarose gels and transferred to Nytran membranes 
(Schleicher and Schuell, Keene, NH) and then suc- 
cessively hybridized with [32p]dCTP labeled 
((0.1-10)" 108 cpm/ktg) cDNA probes for either the 
human IGF-I receptor (bases 1490-2737 encoding 
the ct and fl chains were excised with Eco RI and 
Hind III) [ 19] or human IGF-II (bases 1-854 of a 
cDNA encoding exons 7, 8, and part of 9 excised 
with Pst I) [20], and chicken fl-actin (1.8 kb was 
excised with Pst I) [21]. Densitometry was done and 
the relative A for each hybridization was calculated 
by averaging several exposures that were within the 
linear range of the film. These values were expressed 
as a percentage of untreated (day 0) controls and 
were then divided by a percentage of control values 
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Fig. 1. Effects of IGF-I  and IGF-I receptor antibody on SH- 
SY5Y cell proliferation. SH-SY5Y cells were washed with D M E M  
and plated at a density of  9.104 cells/cm 2 in 96-wells with or 
without ~-IR 3 at 1/~g/ml or various concentrations of IGF-I, as 
indicated in the legend. Cell number was measured after 1, 2, or 
3 days using the MTT assay, as described in Materials and Meth- 
ods. Values represented are the means  of 7-8  wells + S.E.M. from 
a representative experiment performed twice. 
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Results 
Effects of IGF-I and insulin on cell proliferation 
To examine the effects of IGF-I and insulin on 
SH-SY5Y proliferation, cells were plated in DMEM 
with and without IGF-I (0.1, 1, 3, 10 nM) or insu- 
lin (0.1, 1, 3, 5 #g/ml). In the presence of either IGF-I 
or insulin, the cells divided in a dose-dependent fash- 
ion between days 1-3 (Figs. 1 and 2). The maximal 
effects were with either 10 nM IGF-I (Fig. 1) or 5 
#g/ml insulin (Fig. 2) throughout the 3 days. The 
addition of the IGF-I receptor antibody, ~-IR 3, 
blocked both IGF-I and insulin-mediated cellular 
proliferation(Figs. 1 and2), suggestingthatbothpoly- 
peptides stimulate growth via the IGF-I receptor. 
Serum stimulated cell proliferation 
We then examined serum regulated SH-SY5Y 
proliferation by growing cells in increasing concen- 
trations of calf serum. Cell proliferation exhibited a 
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Fig. 2. Effects of  insulin and IGF-I receptor antibody on SH- 
SY5Y cell proliferation. SH-SY5Y cells were washed with D M E M  
and plated at a density of  9.104 cells/cm 2 in 96-weUs with or 
without ct-IR 3 at 1/~g/ml or various concentrations of insulin, as 
indicated in the legend. Cell number was measured after 1, 2, or 
3 days using the MTT assay, as described in Materials and Meth- 
ods. Values represented are the means  of 8 wells + S.E.M. from 
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Fig. 3. (A) Effects of serum on SH-SY5Y cell proliferation. SH- 
SY5Y cells were washed with DMEM and plated in 96-wells at 
a density of 6.104 cells/cm 2 in various concentrations of calf 
serum (CS), as indicated in the legend. Cell number was measured 
on each of 5 days using the MTT assay. Values represented are 
the means of 8 wells _+ S.E.M. from a representative experiment 
performed three times. (B) Effects of IGF-I  receptor antibody and 
serum on SH-SY5Y cell proliferation. SH-SY5Y cells were 
washed with DMEM and plated in 96-wells at a density of 9.104 
cells/cm 2 in serum or serum-free media, with or without ~-IR 3 (1 
#g/ml), as indicated in the legend. Cell number was measured after 
1, 2, or 3 days using the MTT assay, as described in the methods. 
Values represented are the means of 8 wells_+ S.E.M. from a 
representative experiment performed twice. 
serum dose-dependent response, i.e., higher concen- 
trations of serum were correlated with higher num- 
bers of cells (Fig. 3A). To determine what fraction of 
serum-stimulated growth was mediated via the IGF-I 
receptor, SH-SY5Y cells were grown in 0.6% CS in 
the presence of the IGF-I receptor blocking anti- 
body, ~-IR 3. ~-IR 3 completely blocked serum-free 
growth and, as early as day 1, ~-IR 3 inhibited cell 
proliferation when compared to serum-containing 
media alone (Fig. 3B). However, unlike its effects on 
serum-free growth, ~-IR 3 did not completely block 
cell proliferation in the presence of serum (Fig. 3B). 
IGF-H and IGF-I receptor gene expression 
We have previously reported that SH-SY5Y cells 
express three IGF-II  transcripts, 1.8, 4.8 and 6.0 kb 
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Fig. 4. Density dependence of increased IGF-II  mRNA. SH- 
SY5Y cells were plated in paired flasks at (2-16). 104 cells/cm 2 
(as indicated on the X-axis) in DMEM + 10% calf serum and 
allowed to grow for two days. RNA was then isolated from one 
flask of cells at each density. The other flasks were rinsed three 
times and treated with serum-free DMEM, then cultured for an 
additional 24 h, at which time RNA was isolated. Northern analy- 
sis of total RNA was performed, using [32p]cDNA probes for 
IGF-II  and fl-actin. Relative optical densities are expressed on the 
Y-axis as fold increase relative to day 0 for each specific density, 
normalized to fl-actin relative absorbances. Values are from one 
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Fig. 5. Northern analysis of  IGF-I receptor mRNA.  SH-SY5Y 
cells were plated in 6 T150 flasks at 3.7.104 cells/cm 2 in 
D M E M  + 10% calf serum and allowed to grow for 2 days. R NA 
was then isolated from one flask (control) and the other flasks 
were rinsed three times with DM E M ,  and 20 ml fresh D M E M  
added. RNA was then isolated after 1 day (serum-free 1 day) or 
the medium removed and 20 ml D M E M  + 10% calf serum added. 
RNA was then isolated from the remaining flasks after 1, 2, 3 or 
4 days (serum-free 1 day, + serum 1, 2, 3 or 4 days). Northern 
analysis of total RNA was performed, using [32p]cDNA probes 
for IGF-I receptor and fl-actin. A representative autoradiograph 
from one of two experiments is shown in (a). Transcript sizes in 
kilobases are indicated at the right. Autoradiographs exposed 4 h 
(IGF-I receptor) and 36 h (fl-actin). In (b), densitometric analy- 
sis was perfomed on the 11.0 kb IGF-I receptor and 2.1 kb fl-actin 
m R N A  bands of the autoradiograph shown in (a). IGF-I recep- 
tor m R N A  A is expressed on the Y-axis as fold increase relative 
to control, normalized to fl-actin. Each bar corresponds to the 
lanes in part (a). 
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in length [ 12]. In the current study, we analyzed the 
most abundant transcript, the 6.0 kb, as a represent- 
ative measure of total IGF-II content. As previously 
reported [16], IGF-II mRNA levels increased by 
6-fold within 24 h after serum removal. We then 
determined the effects of cell density on IGF-II 
mRNA levels as shown in Fig. 4. At the lowest den- 
sity used (2.5.104 cells/cm 2, subconfluency), IGF-II 
mRNA increased 6-fold above untreated control. 
This effect was reduced at higher plating densities (4 
or 8.104 cells/cm2), and there was no increase in 
IGF-II mRNA content at the highest density em- 
ployed (16.104 cells/cm 2, confluency). Thus, IGF-II 
mRNA increases after 1 day in serum-free media, but 
only at low (subconftuent) cell densities. 
As previously reported, Northern analysis of total 
cellular RNA detected an 11 kb IGF-I receptor 
mRNA transcript [ 12]. We then tested the effects of 
serum removal on IGF-I receptor mRNA levels 
(Fig. 5). For these experiments, cells were grown in 
serum for 2 days, then serum deprived for 1 day, 
followed by addition of serum for 1, 2, 3 or 4 days. 
24 h of serum deprivation increased the expression 
of IGF-I receptor mRNA by 4-fold (Fig. 5). Addi- 
tion of serum to cells which had been initially serum 
deprived produced a mild, but consistent increase of 
IGF-I receptor mRNA compared to IGF-I receptor 
mRNA levels after 1 day of serum deprivation 
(Fig. 5). The highest level of IGF-I receptor mRNA 
was detected after 1 day in serum-free media and 
then 4 days in serum (Fig. 5). 
Discussion 
We have previously shown that IGF-II mediates 
an autocrine growth loop in SH-SY5Y cells via the 
IGF-I receptor [17]. Serum deprivation increases 
SH-SY5Y production of IGF-II immunoreactive 
protein and mRNA [ 16]. Likewise, SH-SY5Y pro- 
liferation is stimulated by addition of exogenous 
IGF-II [ 16] and blocked by antibodies to IGF-II or 
the IGF-I receptor [ 16,17]. In the current study, we 
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have extended our observations on IGF-mediated 
SH-SY5Y growth by examining the growth-promot- 
ing effects of IGF-I and insulin. 
Both IGF-I and insulin stimulated SH-SY5Y pro- 
liferation in a dose-dependent fashion. These effects 
were blocked by the antibody to the IGF-I receptor, 
suggesting that this receptor mediates the effects of 
IGF-I and insulin on SH-SY5Y proliferation. In 
agreement with our results, IGF-I has been shown to 
stimulate DNA synthesis and/or cell proliferation in 
primary neuronal [22] and oligodendrocyte cultures 
[23], rat sympathetic neuroblasts [5] and two other 
neuroblastoma cell lines, rat B104 neuroblastoma 
cells [24] and human SK-N-AS neuroblastoma cells 
[ 10]. Similarly, insulin also acts as a mitogen and can 
increase DNA synthesis in fibroblasts [25-27], 
mammary tumor [28] and human colon cancer cell 
lines [29]. Ishii and colleagues reported that insulin 
increased [3H]thymidine uptake in SH-SY5Y cells 
[30] and, independent of cellular proliferation, insu- 
lin and IGF-I stimulated neuritic outgrowth [30-32] 
and selectively enhanced neurofilament [33] and tu- 
bulin mRNA [34]. 
In the present study, IGF-I-, insulin- and calf 
serum-stimulated increases in cell proliferation were 
mediated via the IGF-I receptor. These data support 
the concept that the growth-promoting effects of the 
IGFs and insulin occur primarily via the IGF-I re- 
ceptor [8]. We found that only high concentrations 
of insulin stimulated SH-SY5Y cell proliferation. 
Similar results have been reported when insulin is 
used as a mitogen in non-neural cells [25-27] or 
when insulin is used as a component of chemically 
defined media [35], implying insulin is acting via the 
IGF-I receptor. Similarly, as we have observed in 
SH-SY5Y cells [ 17] and E1-Badry and colleagues in 
SK-N-AS neuroblastoma cells [ 10], IGF-II-stimu- 
lated neuroblastoma cell growth is also mediated via 
the IGF-I receptor. Collectively, these data suggest 
that cell proliferation can at least partially be medi- 
ated via an IGF/IGF-I  receptor system. Interest- 
ingly, c~-IR 3 did not completely inhibit serum- 
stimulated growth, supporting the concept that other 
mitogenic factors may be involved in SH-SY5Y cell 
growth [17]. Preliminary work from our laboratory 
indicates that epidermal growth factor (EGF) is at 
least one of the other mitogens involved in SH-SY5Y 
growth [36]. 
We have previously speculated that IGF-II ex- 
pression is up-regulated when SH-SY5Y cells are 
subconfluent and, conversely, down-regulated when 
cells reach confluency [ 16]. Such a pattern of IGF-II 
expression would suggest a feedback control mecha- 
nism on cell growth by factors in SH-SY5Y con- 
ditioned media. In support of this idea, we have 
recently reported that addition of serum to subcon- 
fluent cells can decrease IGF-II gene expression [37]. 
In the present study, we observed an inverse rela- 
tionship between IGF-II mRNA expression and cel- 
lular density. After serum removal, subconfluent cells 
expressed high levels of IGF-II mRNA, while con- 
fluent cells expressed lower IGF-II mRNA levels. 
We propose that factors in the conditioned media of 
confluent cells, similar to factors present in serum 
[16,37], regulate an IGF/IGF-I  receptor feedback 
control mechanism. One likely regulatory factor is 
IGF-II itself [ 16], although further work is needed to 
confirm this speculation. 
To further characterize the role of a potential IGF/  
IGF-I receptor feedback mechanism on SH-SY5Y 
growth, we examined IGF-I receptor gene expres- 
sion after serum deprivation and with serum supple- 
mentation. We speculated that, in parallel with 
IGF-II mRNA [ 16], IGF-I receptor mRNA would 
be regulated by changes in serum concentrations. As 
previously observed [ 17], we saw a 4-fold increase in 
IGF-I receptor mRNA after one day of serum dep- 
rivation. Similarly, we have also observed an increase 
in IGF-I receptor mRNA when cells were growth 
inhibited [ 38 ]. With serum addition, there was a small 
but consistent increase in IGF-I receptor mRNA. 
These results imply that IGF-I receptor gene expres- 
sion, like IGF-II, is linked to cell proliferation. Sub- 
confluent (i.e., serum-deprived) SH-SY5Y cells in- 
creased IGF-I receptor mRNA. The addition of 
serum allowed cells to approach confluency via 
I G F - I  receptor mediated growth; thus, the expres- 
sion of I G F - I  receptor m R N A  remained constant  or 
slightly increased. Our findings are consistent with 
studies showing increased I G F - I  receptor m R N A  in 
phorbol ester-treated SH-SY5Y cells [39,40] and 
suggest that I G F - I  receptor gene expression is regu- 
lated by cell growth [17,41,42]. 
In conclusion, our results support  the concept that 
an I G F / I G F - I  receptor system at least partially me- 
diates SH-SY5Y cell proliferation. SH-SY5Y cell 
growth was stimulated by serum, insulin and I G F - I  
via the I G F - I  receptor, which, like IGF- I I ,  exhibited 
density and serum dependent  gene expression. Col- 
lectively, our data suggest the importance of I G F s  in 
regulating nervous system growth. 
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